Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Reliability and Systems Engineering, Beihang University, Beijing, China.
Department of Neurology, Peking University Third Hospital, Beijing, China.
Brain Behav. 2018 Nov;8(11):e01131. doi: 10.1002/brb3.1131. Epub 2018 Oct 19.
To determine the incidence of amyotrophic lateral sclerosis (ALS) in Beijing from 2010 to 2015 and to address the issue of prognosis.
The number of patients diagnosed with ALS was generated from two aspects, namely, diagnostic hospitals and assisted care institutions. By examining the consistency of the overlapping data in terms of age and gender distributions, the number of ALS patients in Beijing was estimated to analyze the incidence. Finally, a prognosis study was carried out by sorting the clinical data of deceased patients to associate time to death with the demographic characteristics, including gender, age at diagnosis, site of onset, body mass index, and lag from onset to diagnosis.
The average yearly incidence was 0.8/100,000 persons, the male-female ratio was 1.63:1, and the mean age at diagnosis was 54.11 years. The mean time from symptom onset to diagnosis was 14.8 months, and the median survival time from diagnosis was 49.4 months. In addition, each of the identified clinical features was related to the survival of the patients with ALS.
The incidence of ALS in Beijing is similar to the rates in Hong Kong and Taiwan but is lower than the rates in Europe and America. In addition, the mean age at onset of the patients in Beijing was early, and overall ALS prognosis appears to be comparable to those reported in recent publications.
确定 2010 年至 2015 年期间北京地区肌萎缩侧索硬化症(ALS)的发病率,并探讨预后问题。
通过诊断医院和辅助护理机构两个方面确定 ALS 患者数量,通过检查年龄和性别分布方面重叠数据的一致性,估算北京地区 ALS 患者的发病率。最后,通过对死亡患者的临床数据进行排序,对患者的预后进行研究,将死亡时间与人口统计学特征(包括性别、诊断时的年龄、发病部位、体重指数和从发病到诊断的时间间隔)相关联。
平均年发病率为 0.8/100,000 人,男女比例为 1.63:1,诊断时的平均年龄为 54.11 岁。从症状出现到诊断的平均时间为 14.8 个月,从诊断到死亡的中位生存时间为 49.4 个月。此外,确定的每个临床特征都与 ALS 患者的生存相关。
北京地区 ALS 的发病率与香港和台湾的发病率相似,但低于欧洲和美洲的发病率。此外,北京地区患者的发病年龄较早,总体 ALS 预后与近期发表的研究报告相似。